Skip to main content

Table 2 Outcomes Based on Microporous Polysaccharide Hemospheres Treatment and Body Mass Index

From: Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial

  Control vs. MPH p BMI < 30 vs. BMI ≥ 30 p
Number of patients 21   21   25   17  
Number of post-op clinic visits 1.0   1.24 0.329 1.2   1.0 0.416
Post-op complication rate 0.0%   4.8% 0.500 4.0%   0.0% 0.416
Total drain days, mean ± SD (range)
All procedures 10.0 ± 4.4 (4–23)   9.14 ± 2.9 5–16) 0.462 8.7 ± 2.8 (4–16)   10.9 ± 4.6 (6–23) 0.058
SM without SLNB 12.6 ± 6.5 (8–23)   9.8 ± 3.6 (7–15) 0.461 8.2 ± 0.8 (7–9)   15.3 ± 6.1 (8–23) 0.036
SM with SLNB 8.1 ± 3.1 (4–16)   8.2 ± 1.6 (5–11) 0.911 7.8 ± 2.1 (4–11)   8.6 ± 3.2 (6–16) 0.506
MRM 11.6 ± 2.9 (8–14)   9.9 ± 3.7 (6–16) 0.398 10.3 ± 3.8 6–16)   11 ± 2.9 (8–15) 0.717
Total drain output (mL), mean ± SD (range)
All procedures 608.8 ± 409.7 (149–2008)   562.6 ± 294.6 (228–1289) 0.677 496.5 ± 244.9 (149–1290)   716.9 ± 446.1 (301–2008) 0.046
SM without SLNB 859.2 ± 675.9 (414–2008)   509.6 ± 299 (328–953) 0.372 391.8 ± 60.0 (328.0–459-0)   1093.9 ± 647 (482–2008) 0.044
SM with SLNB 434.2 ± 219.6 (149–996)   470.4 ± 126.4 (287–685) 0.666 432.4 ± 149.1 (149–685)   477.6 ± 227.5 (301–996) 0.596
MRM 742.7 ± 278.5 (432–1032)   692.7 ± 399.4 (228–1290) 0.812 658.1 ± 352.1 (228–1290)   798.1 ± 355.8 (432–1261) 0.502
1st 72-h output (mL), mean ± SD (range)
All procedures 261.3 ± 88.3 (130–505)   253.2 ± =74.8 (155–403) 0.754 235.7 ± 66.9 (130–403)   288.7 ± 91.1 (177–505) 0.035
SM without SLNB 302.4 ± 118.2 (280–505)   198.4 ± 62.8 (155–201) 0.159 191.6 ± 37.4 (155–247)   336.9 ± 114.4 (249–505) 0.030
SM with SLNB 221 ± 59.7 (130–355)   244.1 ± 49.9 (177–330) 0.368 227.6 ± 55.4 (130–330)   237.1 ± 58.5 (177–353) 0.717
MRM 308.2 ± 82.5 (230–415)   290.8 ± 89.5 (167–403) 0.733 275.4 ± 80.0 (167–403)   332.8 ± 85.7 (221–415) 0.246
  1. SD standard deviation, SM simple mastectomy; SLNB: sentinel lymph node biopsy, MRM: modified radical mastectomy
\